There are no conflicts of interest.
Introduction
A shunt from the left ventricle (LV) to the right atrium (RA) was first described by Gerbode in 1958 . 1 This defect is now primarily seen in patients after valve surgery. 2, 3, 4 We present an unusual case of an acquired Gerbode defect from the LV to the coronary sinus producing cardiac failure following mitral valve replacement (MVR) for the management of left ventricular outflow tract obstruction (LVOTO) in hypertrophic obstructive cardiomyopathy (HOCM).
Patient Profile
The patient was a 73-year-old male who had undergone a right hemicolectomy in 2013 for non-metastatic Duke's A cecal adenocarcinoma followed by chemotherapy and a stroke in
2007.
His symptoms consisted of exertional dyspnea and chest pain. Coronary angiography was saturations increased from 63% in right atrium to 68% in pulmonary artery on right heart catheterization. Attempted percutaneous closure was carried out via a femoral approach.
The defect was identified and a sizer balloon was introduced into the defect with sudden elevation of systemic pressures. At this point it was evident that the communication was between the LV and the coronary sinus which drained into the RA (Figure 4) . Closure of the defect was attempted with occluder devices but they were found to be unstable and obstructing the MVR leaflet. At this point it was necessary to proceed with surgical intervention.
The patient had a redo sternotomy at six weeks post initial surgery, with aortic cannulation, Patients may present acutely with heart failure or cardiogenic shock depending on the shunt size. Three types of Gerbode defects have been described based on the location of the shunt to the tricuspid valve (TV) anatomically. A type 1 defect, the most prevalent, is located above the TV in the region of the membranous ventricular septum. A type 2 defect is below the TV with type 3, a mixture of type 1 and 2 at the level of the TV itself. 2, 3 Awareness of this complication aids in timely diagnosis, as imaging can be difficult to interpret in postoperative patients in the presence of tricuspid regurgitation. The value of percutaneous closure of such defects is, as yet, uncertain and has been associated with significant procedural complication rates. 2 As these patients can be high risk for surgery this was thought to provide a less invasive alternative to surgical repair. Certain closure devices however can interfere with prosthetic valve leaflet function as seen in this case. 4 Surgical correction is more commonly used in non-iatrogenic acquired cases such as infective endocarditis, post MI and trauma. 2 In this case, the recent chemotherapy for adenocarcinoma may have contributed to the friability of tissues encountered at surgery and predisposed to the development of the defect. The attempt at balloon inflation may also have increased the shunt requiring urgent surgical reintervention. This case illustrates a new variant of an acquired Gerbode defect that can be treated effectively by surgical re-intervention with direct visualisation of the defect and patch repair. 
Figure Legend

